Solid Biosciences, Inc. (SLDB)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Solid Biosciences, Inc. (SLDB)
Go deeper and ask any question about SLDB
Company Performance
Current Price
as of Sep 13, 2024$7.93
P/E Ratio
N/A
Market Cap
$306.06M
Description
Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.
Metrics
Overview
- HQCharlestown, MA
- SectorHealth Technology
- IndustryBiotechnology
- TickerSLDB
- Price$7.93+2.72%
Trading Information
- Market Cap$306.06M
- Float84.19%
- Average Daily Volume (1m)215,999
- Average Daily Volume (3m)486,023
- EPS-$3.29
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$25.07M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$26.55M
- EV$67.13M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account